The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, 250000, China
NCT Number: NCT06724068
The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions.
The main question[s] it aims to answer are:
* [The difference of body composition between the individuals of insulin resistance and diabetes] * [The effect of diabetes on body composition]
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Jinan, Shandong, 250000, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This retrospective study uses medical records and diagnostic data from patients with type 2 diabetes and healthy controls obtained from Qianfoshan Hospital from2019 to 2022
Time frame: Retrospective analysis of data collected between2019 and 2022
The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2
Xuan Song
Other
The Correlation Between Diabetes, Insulin Resistance and Body Composition
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02977442
Behavior, Diabetes Mellitus
Baton Rouge, Louisiana, United States
View Trial DetailsNCT03314714
Diabetes Mellitus, Endocrine System Diseases
Düsseldorf, North Rhine-Westphalia, Germany
View Trial DetailsNCT03388697
Diabetes Mellitus, Endocrine System Diseases
Galveston, Texas, United States
View Trial DetailsNCT03135015
Diabetes Mellitus, Endocrine System Diseases
Toronto, Ontario, Canada
View Trial Details